Filter Results:
(7,885)
Show Results For
- All HBS Web
(7,885)
- People (21)
- News (2,650)
- Research (4,142)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,381)
Show Results For
- All HBS Web
(7,885)
- People (21)
- News (2,650)
- Research (4,142)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,381)
- 07 Feb 2018
- News
Athenahealth Taps Former GE CEO Jeff Immelt as Chairman
Photo via BostInno Photo via BostInno Former General Electric CEO Jeffrey Immelt (MBA 1982) has been tapped as the new chairman of athenahealth, the Massachusetts-based health care IT company founded by Jonathan Bush (MBA 1997). Bush, who... View Details
- Fast Answer
Health: data by country and disease
Where to find health data by country & disease? You may begin with: Statista - quick statistics and articles related to the topic View Details
- 23 Jun 2020
- Working Paper Summaries
Dignity, Inequality, and the Populist Backlash: Lessons from America and Europe for a Sustainable Globalization
Keywords: by Rawi Abdelal
- May 6, 2020
- Article
We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic
By: Gary P. Pisano
The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details
Pisano, Gary P. "We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic." Harvard Business Review Digital Articles (May 6, 2020).
- Article
Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated
By: Christopher Ody, Lucy Msall, Leemore S. Dafny, David Grabowski and David Cutler
Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these reductions appear to be illusory or overstated. This is because a... View Details
Keywords: Readmission Rates; Hospitals; Acute Care Hospitals; Medicare; Myocardial Infarction; Heart Failure; Health Care and Treatment
Ody, Christopher, Lucy Msall, Leemore S. Dafny, David Grabowski, and David Cutler. "Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated." Health Affairs 38, no. 1 (January 2019): 36–43.
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details
Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- February 1985
- Background Note
Note on the Boston Area Teaching Hospitals
By: Joseph L. Bower
Bower, Joseph L. "Note on the Boston Area Teaching Hospitals." Harvard Business School Background Note 185-096, February 1985.
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- April 29, 2024
- Editorial
Stemming the Ripple Effect of Untreated Mental Illness: A Prescription for Change: Reimagining U.S. Healthcare
By: Lidia Moura and Susanna Gallani
Moura, Lidia, and Susanna Gallani. "Stemming the Ripple Effect of Untreated Mental Illness: A Prescription for Change: Reimagining U.S. Healthcare." Psychology Today (website) (April 29, 2024).
- January 2013 (Revised February 2013)
- Supplement
Shouldice Hospital Limited (B)
By: James Heskett and Roger Hallowell
Heskett, James, and Roger Hallowell. "Shouldice Hospital Limited (B)." Harvard Business School Supplement 913-405, January 2013. (Revised February 2013.)
- June 2010 (Revised March 2014)
- Teaching Note
Deworming Kenya: Translating Research into Action (A) and (B)
By: Nava Ashraf, Neil Buddy Shah, Rachel Gordon and Elena Moroz
Teaching Note for 910001. View Details
- Web
Getting Involved - Institute For Strategy And Competitiveness
Health Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S. Competitiveness Project FSG Shared Value Initiative Social Progress Imperative AllWorld Network VBHCD Initiative VBHCD... View Details
- December 2007 (Revised January 2008)
- Teaching Note
Eli Lilly: Developing Cymbalta (TN)
By: Elie Ofek
Teaching Note for 507-044 View Details
- April 1989 (Revised July 1992)
- Supplement
Technology Transfer: Anti-Inflammatory Drug (C)
Herzlinger, Regina E. "Technology Transfer: Anti-Inflammatory Drug (C)." Harvard Business School Supplement 189-167, April 1989. (Revised July 1992.)
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Health Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- July–September 2018
- Article
Memory Bias in Observer-Performance Literature
By: Tamara M. Haygood, Samantha N. Smith and Jia Sun
The objective of our study was to determine how authors of published observer–performance experiments dealt with memory bias in study design. We searched American Journal of Roentgenology online and Radiology using “observer study” and “observer performance.” We... View Details
Haygood, Tamara M., Samantha N. Smith, and Jia Sun. "Memory Bias in Observer-Performance Literature." Art. 031412. Journal of Medical Imaging 5, no. 3 (July–September 2018).
- Article
Potentially Long-Lasting Effects of the Pandemic on Scientists
By: Jian Gao, Yian Yin, Kyle R. Myers, Karim R. Lakhani and Dashun Wang
Two surveys of principal investigators conducted between April 2020 and January 2021 reveal that while the COVID-19 pandemic’s initial impacts on scientists’ research time seem alleviated, there has been a decline in the rate of initiating new projects. This dimension... View Details
Gao, Jian, Yian Yin, Kyle R. Myers, Karim R. Lakhani, and Dashun Wang. "Potentially Long-Lasting Effects of the Pandemic on Scientists." Art. 6188. Nature Communications 12 (2021).
- 1994
- Dissertation
Borderline Personality Disorder: Dimension or Category? A Maximum Covariance Analysis
By: William B. Simpson